Healthcare Sales & Marketing Network News: Wolters Kluwer

Searching News Database: Wolters Kluwer

HSMN NewsFeed - 22 Nov 2010
Impax Laboratories Receives Tentative FDA Approval for Generic Cymbalta(R) Delayed-Release 20, 30 and 60 mg Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Aug 2010
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mg
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 14 May 2010
Impax Laboratories Receives Tentative FDA Approval for Generic Opana(R) ER 5, 7.5, 10, 15, 20, 30 and 40 mg Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 5 Apr 2010
Perrigo and Partner Cobrek Announce Settlement of Luxiq(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Apr 2010
Perrigo and Partner Cobrek Launch Generic Version of Evoclin(R) and Announce Settlement of Related Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Mar 2010
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX(R) 0.4mg Capsules and Immediately Commences Shipment
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 19 Oct 2009
Perrigo Announces Dismissal of Duac(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Oct 2009
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Biopharmaceuticals Urology Generics FDA

HSMN NewsFeed - 21 Sep 2009
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
Biopharmaceuticals Generics Dermatology Acquisitions

HSMN NewsFeed - 8 Sep 2009
Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 3 Aug 2009
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Jul 2009
Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jul 2009
Cornerstone Therapeutics Signs Definitive Asset Purchase Agreement to Acquire Commercial Rights to the Antibiotic Factive(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 19 May 2009
Impax Receives FDA Approval for Generic Precose Tablets, 25 mg, 50 mg and 100 mg
Biopharmaceuticals Generics Endocrinology

HSMN NewsFeed - 8 May 2009
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 27 Mar 2009
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
Biopharmaceuticals Neurology FDA Generics

HSMN NewsFeed - 24 Mar 2009
Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 17 Mar 2009
Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
Biopharmaceuticals Generics Litigation FDA

HSMN NewsFeed - 23 Jan 2009
IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 8 Jan 2009
Impax Confirms Patent Challenge Relating to Amrix (R) Extended-Release Capsules, 15mg and 30mg
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 1 Dec 2008
Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive
Devices Personnel

HSMN NewsFeed - 18 Nov 2008
Impax Sued Based on Anda for Generic Cymbalta(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 30 Apr 2008
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 28 Mar 2008
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Mar 2008
IMPAX Comments on Lawsuit Related to Generic Version of Detrol LA(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Dec 2007
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Dec 2007
Lannett Receives FDA Approval for Phentermine
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 Nov 2007
Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
Biopharmaceuticals

HSMN NewsFeed - 19 Nov 2007
IMPAX Comments on Lawsuit Related to Generic Version of Opana(R) ER
Biopharmaceuticals Litigation

HSMN NewsFeed - 16 Oct 2007
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 20 Jun 2007
Auriga Laboratories Announces the Formation of A.T.S. Pharmaceuticals, a Specialty Division dedicated to Dermatology and Gastroenterology
Biopharmaceuticals Dermatology Gastroenterology

HSMN NewsFeed - 20 Jun 2007
FDA Approves Differin(R) (adapalene) Gel, 0.3% for Acne
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 19 Jun 2007
IMPAX Announces Lawsuit Related to Generic Version of Depakote ER
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 May 2007
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 9 May 2007
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 1 May 2007
New Hampshire Law Banning Commercial Use of Prescription Information Declared Unconstitutional
Biopharmaceuticals Litigation

HSMN NewsFeed - 3 Apr 2007
IMPAX Announces FDA Approval of Generic Corzide
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 5 Mar 2007
IMPAX Settles Patent Litigation Related to Generic Wellbutrin(R) XL
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 12 Feb 2007
Wolters Kluwer Health Acquires The Cancer Journal
Oncology Acquisitions

HSMN NewsFeed - 29 Jan 2007
FDA Approves New Indication for YAZ(R) to Treat Acne
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 11 Jan 2007
Lannett to Commence Marketing Meloxicam for Arthritis
Biopharmaceuticals Generics

HSMN NewsFeed - 18 Dec 2006
IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 10 Nov 2006
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 3 Nov 2006
IMPAX Receives FDA Approval for Generic Versions of Urecholine(R) Tablets
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 26 Oct 2006
IMPAX Receives FDA Approval for Generic Version of Colestid(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 5 Oct 2006
FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Oct 2006
IMPAX Announces Dismissal of Lawsuit Related to Generic Concerta(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 7 Sep 2006
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 11 Jul 2006
IMPAX Announces the Launch of IMPAX Pharmaceuticals
Biopharmaceuticals

Return to NewsFeed

Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 2 additional stories matching:
Wolters Kluwer
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!